Table 2.

Proportion of days covered across income categories by medication in cohort with percutaneous coronary intervention, 2017–2019.

Household Income	<$40 k (n = 28,536)	$40 k-<$50 k (n = 8015)	$50 k-<$60 k (n = 8583)	$60 k-<$75 k (n = 10,678)	$75 k-<$100 k (n = 14,452)
PDC, median (Q1, Q3)/Medication = Clopidogrel	0.95 (0.78, 1.00)	0.96 (0.81, 1.00)	0.97 (0.82, 1.00)	0.97 (0.83, 1.00)	0.98 (0.85, 1.00)
PDC, median (Q1, Q3)/Medication = Prasugrel	0.94 (0.76, 1.00)	0.96 (0.79, 1.00)	0.96 (0.8, 1.00)	0.98 (0.87, 1.00)	0.98 (0.84, 1.00)
PDC, median (Q1, Q3)/Medication = Ticagrelor	0.93 (0.75, 1.00)	0.93 (0.76, 1.00)	0.95 (0.81, 1.00)	0.96 (0.83, 1.00)	0.97 (0.84, 1.00)
Full cohort, median (Q1, Q3)	0.95 (0.77, 1.00)	0.96 (0.79, 1.00)	0.96 (0.82, 1.00)	0.97 (0.83, 1.00)	0.98 (0.84, 1.00)